Toxic epidermal necrolysis (TEN) associated with the use of nivolumab (PD-1 inhibitor) for lymphoma

por Griffin, Liezel L., Cove-Smith, Laura, Alachkar, Hana, Radford, John A., Brooke, Rebecca, Linton, Kim M.
Publicado 2018

A real-world experience of second-line nivolumab in mesothelioma patients during the COVID-19 pandemic

por Church, Matt, Taylor, Paul, Summers, Yvonne, Califano, Raffaele, Rafee, Shereen, Dixon, Mairead, Clarke, Lisa, Cove-Smith, Laura
Publicado 2021